Psyence Group Inc (OP:PSYGF)

0.1270 UNCHANGED

Last Price Updated: 12:07 PM EST, Nov 10, 2025 Add to My Watchlist

Price and Volume

Volume	0
Open	0.1270
Bid (Size)	N/A (0)
Ask (Size)	N/A (0)
Prev. Close	0.1270
Today's Range	0.1270 - 0.1270
52wk Range	0.0046 - 0.1270
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Psychedelics Headlines: Anti-inflammatory Effects, Global Drug Survey, 'Synthetic Surprise,' UK's Harm Reduction Hub And More ↗

January 26, 2024

Discover the latest research on psychedelics, from anti-inflammatory effects to end-of-life therapy. New journal issue and online course available.

Via Benzinga

How To Finance A Psychedelics Business? Learn From These Four Companies ↗

April 04, 2023

Clearmind Medicine Announces Pricing of $3.5 Million Public Offering

Via Benzinga

Performance

YTD	N/A	N/A
1 Month	N/A	N/A
3 Month	N/A	N/A
6 Month	+28.0%	+28.0%
1 Year	+1593.3%	+1593.3%

More News

Psyched: Australia As Psychedelics Hub, Advanced Scans Of Brain On DMT, New PAC For Congressional Influence, 9 States Advancing Bills & More ↗

March 27, 2023

Via Benzinga

Psychedelic Research Expands In Australia With Palliative Care Partnership & New MDMA Analog Portfolio ↗

March 21, 2023

Via Benzinga

Psychedelics Update: MDMA Export, 3D Farm, Recovery Center Reopens, Mushroom Extraction & E-Commerce ↗

January 24, 2023

Via Benzinga

Psychedelics Travel: Clinical-Grade Magic Mushrooms Extract Exported From Southern Africa To UK ↗

January 20, 2023

Via Benzinga

6 Psychedelics Companies Take Action: Here Are The Latest, Major Announcements ↗

January 10, 2023

Via Benzinga

Psyched: First Ayahuasca Pill Created, Psychedelics Legalization Predicted, UK's Research Support And More ↗

December 19, 2022

Via Benzinga

Psyence, Revive Therapeutics Ink Private Placements: Capital To Support Drug Trials ↗

December 16, 2022

Via Benzinga

Psychedelics Company Filament Signs Licensing Deal With Psyence In US, UK And EU ↗

December 15, 2022

Via Benzinga

European Psychedelics Research Group Nabs $2M In Seed Funding As Clinical Research Picks Up Speed ↗

October 11, 2022

Via Benzinga

International Magic Mushrooms: Where Are They Produced And Where Are They Headed? ↗

September 29, 2022

Via Benzinga

Psyched: Magic Mushrooms Vs. Psychotherapy, Psilocybin For Frontline Health Workers & Protecting Peyote ↗

September 26, 2022

Via Benzinga

Magic Mushrooms Vs. Psychotherapy For Incurable Cancer Diagnosis Moves Forward In UK Clinical Trials ↗

September 19, 2022

Via Benzinga

Psyched: Big Pharma's Sanofi Enters Psychedelics Space, DNA From 80 Psilocybe Mushrooms Published Online, Maine Psychedelics Bill Shelved ↗

April 25, 2022

Via Benzinga

Psyence, Filament Strike Magic Mushroom Product Licensing Agreement: What You Need To Know ↗

April 19, 2022

Via Benzinga

Frequently Asked Questions

Is Psyence Group Inc publicly traded?

Yes, Psyence Group Inc is publicly traded.

What exchange does Psyence Group Inc trade on?

Psyence Group Inc trades on the OTC Traded

What is the ticker symbol for Psyence Group Inc?

The ticker symbol for Psyence Group Inc is PSYGF on the OTC Traded

What is the current price of Psyence Group Inc?

The current price of Psyence Group Inc is 0.1270

When was Psyence Group Inc last traded?

The last trade of Psyence Group Inc was at 11/10/25 12:07 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.